Active · per the CBE, 19 September 2026

VIVES II - Louvain Technology Fund

BE0838819178

Rechtspersoon Public limited company

Place de l'Université 16 box 27, 1348 Ottignies-Louvain-la-Neuve

Active for

15 year

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Busy address KBO

    26 other companies have their registered office at the same address; threshold 10.

  • Not on Peppol Peppol

    Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

VIVES II - Louvain Technology Fund from Ottignies-Louvain-la-Neuve, company number BE0838819178, closed financial year 2025 with a result of € 3.5 million after tax. For that financial year VIVES II - Louvain Technology Fund recorded a gross margin of € -22,791 and equity of € 7.7 million. Compared with financial year 2024, the result moved from € -4.9 million to € 3.5 million. Profitable, and profit is growing. The buffer shrank hard: equity is 54 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.

What it is worth Shrank hard

€ 7.7 million

▼ 54% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 3.5 million

▲ still € 4.9 million loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 151,932

▼ 2% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -6.4 million.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 8,409

▼ 55% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € -572,200 € -605,006 € -49,471 € -22,791 ▲ € 26,680
Profit after taxes € 3,226,807 € -3,455,245 € -4,851,065 € 3,489,304 ▲ € 8.3 million
Equity € 22,471,996 € 19,625,722 € 16,914,657 € 7,711,825 ▼ 54%
Total debts € 146,635 € 155,567 € 22,489 € 12,409 ▼ 45%
Cash € 1,618,427 € 388,857 € 155,233 € 151,932 ▼ 2%
Retained profit € -1,593,090 € -5,048,335 € -9,899,400 € -6,410,096 ▲ € 3.5 million
Balance sheet total € 22,618,631 € 19,781,289 € 16,937,146 € 7,724,234 ▼ 54%

Key figures of VIVES II - Louvain Technology Fund, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VIVES II - Louvain Technology Fund?

What happened at VIVES II - Louvain Technology Fund in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • Vives Partners SRL stepped down as director. NBB
  • New annual accounts for financial year 2025: profit of € 3.5 million. Source: NBB ↗
  • IRD SA stepped down as director. NBB
  • ING Belgique stepped down as director. NBB
  • BPI France Investissement stepped down as director. NBB
  • Invest.Bw stepped down as director. NBB
  • Pascal Dumont stepped down as director. NBB
  • SFPI stepped down as director. NBB

In short

From € 3.2 million profit in 2022 to € 3.5 million profit in 2025.

Best year ever: 2025, with € 3.5 million profit.

Management

The stake of SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT, SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON, SOPARTEC comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

VIVES II - Louvain Technology Fund
Tessares 28.3%
Axinesis 25.4%
Botalys 11.6%
+3

The shares are held by SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT (11.7%), SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON (9.4%) and SOPARTEC (2.4%). It owns 28.3% of Tessares, 25.4% of Axinesis, 12.5% of Novadip Biosciences , 11.6% of Botalys, 9.8% of Virovet and 3.5% of Aphea.Bio itself.

See the full network in the app

Directors

According to the 2025 annual accounts

IRD SA

Director · represented by Hélène Guillon épouse Cannard

since 2021 · until 2026

Vives Partners SRL

Managing director · represented by Philippe Durieux

Also active at: NOVADIP BIOSCIENCES, TESSARES, AXINESIS, Sunrise, ViroVet, The Akkermansia Company, VOCSens, Vives Inter-University Fund +4 more

since 2024 · until 2026

BPI France Investissement

Director · represented by Sandra Goussu

since 2021 · until 2026

since 2021 · until 2026

Pascal Dumont

Director

Also active at: THEODORUS III

since 2021 · until 2026

Didier Lamote

Director

Also active at: Capricorn SCF, SDG Frontier Fund, CAPRICORN HEALTH-TECH FUND

since 2022 · until 2026

Jean-François Burguet

Director

since 2021 · until 2025

Charles de Lidekerke

Chairman of the board

since 2021 · until 2026

Participations

Establishments

Establishment units

Physical locations of this company

Registered office

Place de l'Université 16 box 27

1348 Ottignies-Louvain-la-Neuve

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0838.819.178
VAT number
BE 0838.819.178
Registered office
Place de l'Université 16 bus 27, 1348 Ottignies-Louvain-la-Neuve
Names & denominations
VIVES II - Louvain Technology Fund · VIVES II
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
25 August 2011
Peppol
Not registered

Frequently asked questions

What is the address of VIVES II - Louvain Technology Fund?
The registered office of VIVES II - Louvain Technology Fund is located at Place de l'Université 16 box 27, 1348 Ottignies-Louvain-la-Neuve.
Is VIVES II - Louvain Technology Fund still active?
Yes. According to the CBE (19 September 2026) VIVES II - Louvain Technology Fund is active, legal situation “Normale toestand”, started on 25 August 2011.
Is VIVES II - Louvain Technology Fund registered on Peppol?
No, VIVES II - Louvain Technology Fund is currently not registered on the Peppol network.
What is the enterprise number of VIVES II - Louvain Technology Fund?
The enterprise number of VIVES II - Louvain Technology Fund is BE0838819178.
When was VIVES II - Louvain Technology Fund founded?
VIVES II - Louvain Technology Fund was founded on 25 August 2011.
Who owns VIVES II - Louvain Technology Fund?
The shares are held by SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT (11.7%), SOCIETE D'INVESTISSEMENT ET DE FINANCEMENT DU BRABANT WALLON (9.4%) and SOPARTEC (2.4%). It owns 28.3% of Tessares, 25.4% of Axinesis, 12.5% of Novadip Biosciences , 11.6% of Botalys, 9.8% of Virovet and 3.5% of Aphea.Bio itself.